Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Guo, 2014, The role of glioma stem cells in glioma tumorigenesis, Front Biosci-Landmrk, 19, 818, 10.2741/4249
Grp, 2010, High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, 21, v190, 10.1093/annonc/mdq187
Labombardi, 2012, No Consistent Relationship of Glioblastoma Incidence and Cytomegalovirus Seropositivity in Whites, Blacks, and Hispanics, Anticancer Res, 32, 1113
Grp, 2012, Epidemiology of glial and non-glial brain tumours in Europe, Eur J Cancer, 48, 1532, 10.1016/j.ejca.2011.12.013
Gijtenbeek, 2009, Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, Lancet Oncol, 10, 459, 10.1016/S1470-204570025-7
Moura-Neto, 2012, Glioblastoma: Therapeutic challenges, what lies ahead, Bba-Rev Cancer, 1826, 338, 10.1016/j.bbcan.2012.05.004
Wrensch, 2006, Epidemiology and molecular pathology of glioma, Nat Clin Pract Neuro, 2, 494, 10.1038/ncpneuro0289
Berger, 2008, Glioma extent of resection and its impact on patient outcome, Neurosurgery, 62, 753, 10.1227/01.Neu.0000310769.20996.Bd
Palti, 2013, Tumor treating fields: a new frontier in cancer therapy, Ann N Y Acad Sci, 1291, 86, 10.1111/nyas.12112
Palti, 2004, Disruption of cancer cell replication by alternating electric fields, Cancer Res, 64, 3288, 10.1158/0008-5472.Can-04-0083
Weinberg, 2011, Tumor treating fields: concept, evidence and future, Expert Opin Inv Drug, 20, 1099, 10.1517/13543784.2011.583236
Mangiola, 2012, Electric fields for the treatment of glioblastoma, Expert Rev Neurother, 12, 1181, 10.1586/Ern.12.112
Vymazal, 2012, Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields, World J Surg Oncol, 10, 10.1186/1477-7819-10-220
Ryffel, 2007, Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors, P Natl Acad Sci USA, 104, 10152, 10.1073/pnas.0702916104
Palti, 2009, Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields), BMC Med Phys, 9, 1, 10.1186/1756-6649-9-1
Ram, 2014, Ef. Interim Analysis of the Ef-14 Trial: A Prospective, Multi-Center Trial of Novottf-100a Together with Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed Gbm, Neuro-Oncology, 16, 10.1093/neuonc/nou265.40
Palti, 2009, Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs, Clin Exp Metastas, 26, 633, 10.1007/s10585-009-9262-y
Yoon, 2014, Inhibition of brain tumor cell proliferation by alternating electric fields, Appl Phys Lett, 105, 10.1063/1.4902112
Yung, 1999, Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials, J Clin Oncol, 17, 2572, 10.1200/JCO.1999.17.8.2572
Polverini, 2005, Combination treatment significantly enhances the efficacy of antitumor therapy by preferentially targeting angiogenesis, Lab Invest, 85, 756, 10.1038/labinvest.3700272
Weinberg, 2008, Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis, Dev Cell, 14, 818, 10.1016/j.devcel.2008.05.009
Berx, 2013, Regulatory networks defining EMT during cancer initiation and progression, Nat Rev Cancer, 13, 97, 10.1038/nrc3447
Jun, 2002, Recent advances in insulin gene therapy for type 1 diabetes, Trends Mol Med, 8, 62, 10.1016/S1471-4914(02)02279-7
Jelkmann, 2005, Review: hypoxia-inducible factor-1 (HIF-1) : a novel transcription factor in immune reactions, J Interferon Cytokine Res, 25, 297, 10.1089/jir.2005.25.297
de Bruin, 2012, E2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1, Embo J, 31, 3871, 10.1038/emboj.2012.231
Chen, 2008, Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells, Carcinogenesis, 29, 1807, 10.1093/carcin/bgn162
Kwon, 2004, Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction, Oncogene, 23, 1845, 10.1038/sj.onc.1207307
Wolf, 2003, Tumour-cell invasion and migration: Diversity and escape mechanisms, Nat Rev Cancer, 3, 362, 10.1038/nrc1075
Weinberg, 2009, The basics of epithelial-mesenchymal transition, J Clin Invest, 119, 1420, 10.1172/JCI39104
Sleeman, 2006, Complex networks orchestrate epithelial-mesenchymal transitions, Nat Rev Mol Cell Biol, 7, 131, 10.1038/nrm1835
Yang, 2013, Epithelial-mesenchymal plasticity in carcinoma metastasis, Genes Dev, 27, 2192, 10.1101/gad.225334.113
Pintzas, 2009, Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic, Biochim Biophys Acta, 1796, 75, 10.1016/j.bbcan.2009.03.002
Folkman, 1996, Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis, Cell, 86, 353, 10.1016/S0092-8674(00)80108-7
Stetler-Stevenson, 1991, Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation, Cell, 64, 327, 10.1016/0092-8674(91)90642-C
Fusenig, 1997, Halting angiogenesis suppresses carcinoma cell invasion, Nat Med, 3, 1222, 10.1038/Nm1197-1222
Nieto, 2009, Epithelial-mesenchymal transitions in development and disease, Cell, 139, 871, 10.1016/j.cell.2009.11.007
Di Benedetto, 2012, Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion, Cell Adh Migr, 6, 547, 10.4161/cam.23332
Hudlicka, 2000, Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle, Am J Physiol-Heart C, 279, H1540, 10.1152/ajpheart.2000.279.4.H1540
Rundhaug, 2003, Matrix metalloproteinases, angiogenesis, and cancer - Commentary re: A. C. Lockhart et al., reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor. Clin. Cancer Res., 9:00-00, 2003, Clin Cancer Res, 9, 551
Matrisian, 1997, Changing views of the role of matrix metalloproteinases in metastasis, J Natl Cancer I, 89, 1260, 10.1093/jnci/89.17.1260
Werb, 2002, New functions for the matrix metalloproteinases in cancer progression, Nat Rev Cancer, 2, 161, 10.1038/nrc745
Edwards, 2008, The regulation of matrix metalloproteinases and their inhibitors, Int J Biochem Cell B, 40, 1362, 10.1016/j.biocel.2007.12.006
Aggarwal, 2004, Nuclear factor-kappa-B: The enemy within, Cancer Cell, 6, 203, 10.1016/j.ccr.2004.09.003
Pfeilschifter, 2000, Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways, J Immunol, 165, 5788, 10.4049/jimmunol.165.10.5788
Jang, 2012, N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell invasion through suppressing NF-KB activation and inhibiting matrix metalloproteinase-9 expression, J Cell Biochem, 113, 2845, 10.1002/jcb.24159
Jiang, 2012, Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway, Int J Oncol, 41, 1809, 10.3892/ijo.2012.1617
Rathmell, 2011, Looking beyond inhibition of VEGF/mTOR: emerging targets for renal cell carcinoma drug development, Curr Clin Pharmacol, 6, 199, 10.2174/157488411797189389
Van Waes, 2007, Nuclear factor-kappaB in development, prevention, and therapy of cancer, Clin Cancer Res, 13, 1076, 10.1158/1078-0432.CCR-06-2221
Shen, 2013, Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-kappa B pathway, Oncol Rep, 29, 571, 10.3892/or.2012.2165
He, 2012, Notch2 regulates matrix metallopeptidase 9 via PI3K/AKT signaling in human gastric carcinoma cell MKN-45, World J Gastroentero, 18, 7262, 10.3748/wjg.v18.i48.7262
Yoo, 2011, Metastatic function of BMP-2 in gastric cancer cells: The role of PI3K/AKT, MAPK, the NF-kappa B pathway, and MMP-9 expression, Exp Cell Res, 317, 1746, 10.1016/j.yexcr.2011.04.006
Ravani, 2000, Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells, Cancer Res, 60, 1254